Lavie Bio

Ness Ziona, Israel Founded: 2019 • Age: 7 yrs Acquired By ICL
Microbes-based crop solutions are developed for bio-stimulation and pest protection.
Request Access

About Lavie Bio

Lavie Bio is a company based in Ness Ziona (Israel) founded in 2019 by Rafi Meissner and Hagai Karchi was acquired by ICL in April 2025.. Lavie Bio has raised $10 million across 1 funding round from investors including ICL Group and ICL Planet Startup Hub. Lavie Bio offers products and services including Bio-Stimulants and Bio-Pesticides. Lavie Bio operates in a competitive market with competitors including Evogene, Kaiima, NRGene, NextFerm and PlantArcBio, among others.

  • Headquarter Ness Ziona, Israel
  • Founders Rafi Meissner, Hagai Karchi
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10 M (USD), Series A

    Aug 23, 2022

  • Investors
    ICL Group

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    ICL

    (Apr 21, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lavie Bio

Lavie Bio offers a comprehensive portfolio of products and services, including Bio-Stimulants and Bio-Pesticides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enhance plant performance and yield through natural microbial treatments.

Protect crops from pests and diseases using microbiome-based solutions.

People of Lavie Bio
Headcount 10-50
Employee Profiles 4
Board Members and Advisors 8
Employee Profiles
People
Sharon Berezin Alves
Field Trials Agronomist
People
Michal Shoresh
Director of Research
People
Michael Ionescu
VP, Research

Unlock access to complete

Board Members and Advisors
people
Ofer Haviv
Chairman
people
Trevor Thiessen
Board Member
people
Frederic C. Beudot
Board Member
people
Sassi Masliah
Board Member

Unlock access to complete

Funding Insights of Lavie Bio

Lavie Bio has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $10.0M
  • First Round

    (23 Aug 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Series A - Lavie Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lavie Bio

Lavie Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ICL Group and ICL Planet Startup Hub. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Specialty minerals and chemicals products are manufactured for industrial use.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lavie Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lavie Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lavie Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lavie Bio

Lavie Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evogene, Kaiima, NRGene, NextFerm and PlantArcBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of plant traits
domain founded_year HQ Location
Develops hybrid castor bean seeds for modern large-scale farming systems.
domain founded_year HQ Location
AI-based genomic tools are provided for agricultural research and breeding.
domain founded_year HQ Location
Non-GMO technology is provided for developing improved yeast strains.
domain founded_year HQ Location
Gene discovery platform for crop productivity traits is developed.
domain founded_year HQ Location
Grain quality analysis software is developed for milling optimization.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Lavie Bio

When was Lavie Bio founded?

Lavie Bio was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Where is Lavie Bio located?

Lavie Bio is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.

Who is the current CEO of Lavie Bio?

Ofer Haviv is the current CEO of Lavie Bio.

Is Lavie Bio a funded company?

Lavie Bio is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Aug 23, 2022.

What does Lavie Bio do?

Lavie Bio was founded in 2019 in Ness Ziona, Israel, within the ag-biologicals sector. Microbes-based products are developed using genomics and microbiome technologies to address crop needs. Bio-stimulants are offered for corn and wheat enhancement, while biopesticides target fusarium species and mildew fungi. Operations focus on diversified solutions for agricultural protection and yield improvement in global markets.

Who are the top competitors of Lavie Bio?

Lavie Bio's top competitors include NRGene, Evogene and Equinom.

What products or services does Lavie Bio offer?

Lavie Bio offers Bio-Stimulants and Bio-Pesticides.

Who are Lavie Bio's investors?

Lavie Bio has 2 investors. Key investors include ICL Group, and ICL Planet Startup Hub.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available